Cancer Immunotherapy Paradigms, Practice and Promise /
This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical tr...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction
- Historical Perspectives and Current Trends in Cancer Immunotherapy
- T cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
- Adoptive T Cell Transfer
- Dendritic Cell-Based Cancer Immunotherapy: Achievements and novel concepts
- Peptide and Protein-based Cancer Vaccines
- Antigen Targeting to Dendritic Cells for Cancer Immunotherapy
- Cytokines in the Treatment of Cancer
- Immune Co-signaling to Treat Cance
- Managing Regulatory T cells
- Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and therapeutic perspectives
- Antibodies as Cancer Immunotherapy
- Targeted Toxins in Cancer Immunotherapy
- Miscellaneous Approaches and Considerations: TLR agonists and other inflammatory agents, anti-chemokine agents, infectious agents, tumor stroma targeting, age and sex effects, and miscellaneous small molecules
- Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies
- Monitoring Antigen-Specific Responses in Clinical Trials of Immunotherapy
- Index.
